Elevance Health (ELV) said Thursday it expects to report Q1 adjusted net income of $11.97 per diluted share, up from $10.64 per share a year ago.
Analysts polled by FactSet expected $11.32.
The company said it plans to reaffirm its full-year 2025 adjusted net income guidance of $34.15 to $34.85 per diluted share. It plans to report its Q1 results April 22.
Price: 424.73, Change: -10.31, Percent Change: -2.37
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.